biotech · Glioblastoma · Recurrent Brain Metastases · GTBP
GT Biopharma
GT Biopharma trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Brisbane, USA
- Founded
- 1973
- Employees
- 8
- Programs
- 8
- Drugs
- 7
- Patents
- 1
GT Biopharma clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to GT Biopharma programs — each row shows trial ID, program name, phase, status, and indication.
GT Biopharma trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for GT Biopharma.
-
GTM-103 — Approved
Clinical update -
Stereotactic Radiation Therapy — Approved
Clinical update -
Stereotactic Radiation Therapy — Phase 3
Clinical update -
Cesium-131 brachytherapy — Phase 2
Clinical update -
Temozolomide — Phase 3
Clinical update -
GTB-3550 TriKE® Phase I — Phase 2
Clinical update -
GTB-5550 — Phase 1
Clinical update -
Semaglutide — Unknown
Clinical update